Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;60(1):57-64.
doi: 10.1136/jmedgenet-2021-108179. Epub 2021 Dec 7.

Biallelic ANGPT2 loss-of-function causes severe early-onset non-immune hydrops fetalis

Affiliations

Biallelic ANGPT2 loss-of-function causes severe early-onset non-immune hydrops fetalis

Marie F Smeland et al. J Med Genet. 2023 Jan.

Abstract

Background: Hydrops fetalis, a pathological fluid accumulation in two or more body compartments, is aetiologically heterogeneous. We investigated a consanguineous family with recurrent pregnancy loss due to severe early-onset non-immune hydrops fetalis.

Methods and results: Whole exome sequencing in four fetuses with hydrops fetalis revealed that they were homozygous for the angiopoietin-2 (ANGPT2) variant Chr8 (GRCh37/Hg19): 6385085T>C, NM_001147.2:c.557A>G. The substitution introduces a cryptic, exonic splice site predicted to result in loss of 10 nucleotides with subsequent shift in reading frame, leading to a premature stop codon. RNA analysis in the heterozygous parents demonstrated loss of detectable mutant allele, indicative of loss-of-function via nonsense-mediated mRNA decay. Serum ANGPT2 levels were reduced in the parents. In a pregnancy with a healthy, heterozygous child, transiently increased fetal nuchal translucency was noted.

Conclusion: Pathogenic heterozygous ANGPT2 missense variants were recently shown to cause autosomal dominant primary lymphoedema. ANGPT2 is a ligand of the TIE1-TIE2 (tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domains 1 and 2) pathway. It is critical to the formation and remodelling of blood and lymphatic vessels and is involved in vessel maintenance. ANGPT2 knockout mice die from generalised lymphatic dysfunction. We show here that a homozygous pathogenic variant causes loss-of-function and results in severe early-onset hydrops fetalis. This is the first report of an autosomal recessive ANGPT2-related disorder in humans.

Keywords: female urogenital diseases and pregnancy complications; genetics; loss of function mutation; medical.

PubMed Disclaimer

Conflict of interest statement

Competing interests: PB has received support from Belgian Fonds de la Recherche Scientifique for attending meetings and/or travel.

Figures

Figure 1
Figure 1
Pedigree of a family with ANGPT2 c.557A>G r.557_566del. Triangles in black are fetal losses with hydrops fetalis, and white triangles with question mark are early pregnancy losses not amenable to evaluation. Created by the authors. Het, heterozygous NM_001147.2:c.557A>G r.557_566del; Hom, homozygous NM_001147.2:c.557A>G r.557_566del; N/A, not available for genetic analysis; WT, wild-type, homozygous NM_001147.2:c.557A r.557A.
Figure 2
Figure 2
Photograph of a fetus (III-5) with intrauterine death at 27 gestational weeks. Note the severe subcutaneous oedemas, deformed facial features and large cystic hygroma of the neck. Created by the authors.
Figure 3
Figure 3
DNA and RNA analyses. Sequencing of the pathogenic variant ANGPT2 c.557A>G (heterozygous, represented by an R) and the benign marker variant c.882 G>A (heterozygous C/T in the genomic minus strand alignment from WES) in DNA (top) and RNA isolated from lymphocytes from individual II-1 (bottom). RNA only contains one of the two alleles (WT for the mutation position). Created by the authors. WES, whole exome sequencing; WT, wild-type.

References

    1. Bellini C, Hennekam RCM. Non-Immune hydrops fetalis: a short review of etiology and pathophysiology. Am J Med Genet A 2012;158A:597–605. 10.1002/ajmg.a.34438 - DOI - PubMed
    1. Sileo FG, Kulkarni A, Branescu I, Homfray T, Dempsey E, Mansour S, Thilaganathan B, Bhide A, Khalil A. Non-Immune fetal hydrops: etiology and outcome according to gestational age at diagnosis. Ultrasound Obstet Gynecol 2020;56:416–21. 10.1002/uog.22019 - DOI - PubMed
    1. Society for Maternal-Fetal Medicine (SMFM), Norton ME, Chauhan SP, Dashe JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol 2015;212:127–39. 10.1016/j.ajog.2014.12.018 - DOI - PubMed
    1. Lockwood CJ JS. Nonimmune hydrops fetalis Waltham, MA: UpToDate, 2020. Available: https://www.uptodate.com/contents/nonimmune-hydrops-fetalis
    1. Santolaya J, Alley D, Jaffe R, Warsof SL. Antenatal classification of hydrops fetalis. Obstet Gynecol 1992;79:256–9. - PubMed

Publication types